Antibacterial Agents TRIZ Cases

Selected pyrrolopyrimidine compounds inhibit Mer tyrosine kinase signaling pathways.

An acid pump antagonist inhibits gastric acid secretion to normalize gastrointestinal motility.

Alpha-galactosyl ceramide analogs activate natural killer T cells and mature dendritic cells through specific chemical structure modifications.

NK-lysin peptides disrupt microbial membranes to overcome beta-lactamase hydrolysis and restore antibiotic efficacy.

Microparticle carriers deliver antigenic epitopes to overcome mucosal administration stability issues and induce protective immunity.

LasR inhibitors block quorum sensing signaling in Gram-negative bacteria.

Recombinant PlpE lipoprotein serves as a targeted antigen to induce cross-protective immunity against Pasteurella multocida infections in animals.

Novel substituted quinoline derivatives with unsaturated carbon chains inhibit the F1F0 ATP synthase to treat drug-resistant tuberculosis.

Pyridinium ionic liquid catalyzes imidazole synthesis via ultrasound, eliminating hazardous solvents while maintaining high antimicrobial efficacy.

Analyzing CD45+ monocyte profiles resolves diagnostic ambiguity in bacterial sepsis, improving treatment accuracy and reducing mortality.

Reducing telavancin exposure via creatinine-based dosing lowers acute kidney injury and mortality in renal patients.

Hemin derivatives conjugated with amino acids disrupt microbial lipid membranes, resolving toxicity and resistance issues in antimicrobial therapy.

An EPS solvating system uses metal ion chelation and surfactants to disrupt bacterial biofilms in chronic wounds.

Lactic acid maintains low vaginal pH while a bioadhesive matrix traps sperm and prolongs tenofovir release, reducing irritation from nonoxynol-9.

Macrocyclic compounds target Pseudomonas aeruginosa infections, overcoming resistance to current antimicrobial agents.

Zirconium phosphate compound retains silver ions to prevent resin coloring and enhance heat resistance.

Aqueous ethanol extraction with polymeric resin yields high-titre proanthocyanidin concentrates without toxic solvents or extreme temperatures.

Engineered anaerobic bacteria produce (R)-3-hydroxybutyric acid to modulate gut flora.

Eucalyptus oil mediates chlorhexidine penetration through the stratum corneum to treat subcutaneous Staphylococcus epidermidis infections.

Replacing chemical synthesis with microbial biosynthesis reduces manufacturing complexity while generating diverse orthosomycin compounds.

A pharmaceutical composition with a volatile vehicle and wetting agent enhances active ingredient penetration through the nail plate.

Systemic PAMAM dendrimer nanoparticles accumulate in activated retinal microglia, reducing neovascularization by 80% without frequent intraocular injections.

Optimizing excipient concentrations prevents protein denaturation during storage, maintaining stability for six months without unpredictable effects.

Hydroxypropyl methylcellulose phthalate enhances oxazole compound water solubility to treat mycobacterium tuberculosis infections.

Rotating the loom 90 degrees creates a vertical shed that bypasses shuttle limitations for cables and hoses.

Peptides merge bacterial lysis and lipopolysaccharide neutralization to overcome antibiotic resistance and septic shock risks.

Small molecule compounds inhibit the PscE-PscG protein interaction to block virulence machinery assembly in Pseudomonas aeruginosa.

Oxo-eT spacers link saccharides to carrier proteins via stable thioether bonds, eliminating reactive sites that disrupt protein functionality.

Bifunctional compounds link CDK8 inhibitors to E3 ligase ligands to induce targeted protein degradation.

Chemical desulphation converts sulphated chondroitin into non-sulphated forms, resolving production inefficiencies while enhancing therapeutic efficacy.

Benzo[c]phenanthridine derivatives inhibit FtsZ polymerization via competitive GTP binding, treating multidrug-resistant infections with reduced toxicity.

Cholesterol nanosomes stabilize Amphotericin B in saline, preventing precipitation and reducing nephrotoxicity.

Hydroxypropyl beta-cyclodextrin forms an inclusion complex with oritavancin, reducing infusion volume and time while maintaining therapeutic efficacy.

Chemical synthesis of hybrid peptide epitopes eliminates biological contamination risks while enabling scalable vaccine production.

Cross-linked polymer system enables controlled swelling and sustained drug release, resolving variable resorption rates that compromise tissue integration.

Targeted amino acid mutations increase binding avidity and therapeutic potency while reducing preparation complexity of IL-6R inhibitors.

Structured polypeptides use segmented cyclic domains and flexible linkers to bind human plasma kallikrein with high affinity.

Biocompatible organogel composition enhances active agent absorption through skin barriers.

Inverting the C-12 methyl stereochemistry in mutilin rings resolves insufficient Gram-negative bacterial activity while maintaining Gram-positive efficacy.